Search

Search Constraints

You searched for: Author/Creator Zhao, Jinge

Search Results

1. AKR1C3 expression in primary lesion rebiopsy at the time of metastatic castration‐resistant prostate cancer is strongly associated with poor efficacy of abiraterone as a first‐line therapy. Issue 13 (11th July 2019)

2. Circulating tumour DNA reveals genetic traits of patients with intraductal carcinoma of the prostate. (3rd August 2021)

5. Does ductal adenocarcinoma of the prostate (DA) have any prognostic impact on patients with de novo metastatic prostate cancer?. Issue 14 (21st August 2019)

6. Exosomal TUBB3 mRNA expression of metastatic castration‐resistant prostate cancer patients: Association with patient outcome under abiraterone. (28th July 2021)

7. Novel nomograms for castration‐resistant prostate cancer and survival outcome in patients with de novo bone metastatic prostate cancer. (7th June 2018)

8. The heterogeneity of intraductal carcinoma of the prostate is associated with different efficacy of standard first‐line therapy for patients with metastatic castration‐resistant prostate cancer. Issue 15 (26th August 2021)

9. The impact of multifocal perineural invasion on biochemical recurrence and timing of adjuvant androgen‐deprivation therapy in high‐risk prostate cancer following radical prostatectomy. Issue 12 (27th July 2017)

10. The Impact of Renal Impairment on Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors. (27th November 2020)